Phosphoprotein-based drug target activation mapping for precision oncology: a view to the future

被引：2
|
作者：
Pierobon, Mariaelena [1 ]
Petricoin, Emanuel F., III [1 ]
Wulfkuhle, Julia D. [1 ]
机构：
[1] George Mason Univ, Ctr Appl Prote & Mol Med, Sch Syst Biol, Manassas, VA 20110 USA
来源：
EXPERT REVIEW OF PROTEOMICS | 2018年 / 15卷 / 11期
关键词：
Drug target; activation mapping; oncology; phosphoproteomics; BREAST-CANCER; BLOCKADE; PD-L1;
D O I：
10.1080/14789450.2018.1531709
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：851 / 853
页数：3
相关论文
共 8 条
  • [1] Antibody Drug Conjugates (ADCs): Shaping the Future of Precision Oncology
    Sevilla-Carrillo, Irene
    Garcia-Tercero, Eloina
    Alonso-Moreno, Carlos
    Moya-Lopez, Carmen
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2025,
  • [2] Protein drug target activation homogeneity in the face of intra-tumor heterogeneity: implications for precision medicine
    Parasido, Erika Maria
    Silvestri, Alessandra
    Canzonieri, Vincenzo
    Belluco, Claudio
    Diodoro, Maria Grazia
    Milione, Massimo
    Melotti, Flavia
    De Maria, Ruggero
    Liotta, Lance
    Petricoin, Emanuel F.
    Pierobon, Mariaelena
    ONCOTARGET, 2017, 8 (30) : 48534 - 48544
  • [3] Protein Pathway Activation Mapping of Brain Metastasis from Lung and Breast Cancers Reveals Organ Type Specific Drug Target Activation
    Improta, Giuseppina
    Zupa, Angela
    Fillmore, Helen
    Deng, Jianghong
    Aieta, Michele
    Musto, Pellegrino
    Liotta, Lance A.
    Broaddus, William
    Petricoin, Emanuel F., III
    Wulfkuhle, Julia D.
    JOURNAL OF PROTEOME RESEARCH, 2011, 10 (07) : 3089 - 3097
  • [4] Therapeutic drug monitoring-based precision dosing of oral targeted therapies in oncology: a prospective multicenter study
    Groenland, S. L.
    van Eerden, R. A. G.
    Westerdijk, K.
    Meertens, M.
    Koolen, S. L. W.
    Moes, D. J. A. R.
    de Vries, N.
    Rosing, H.
    Otten, H.
    Vulink, A. J. E.
    Desar, I. M. E.
    Imholz, A. L. T.
    Gelderblom, H.
    van Erp, N. P.
    Beijnen, J. H.
    Mathijssen, R. H. J.
    Huitema, A. D. R.
    Steeghs, N.
    Dutch Pharmacology Oncology Grp DPOG
    ANNALS OF ONCOLOGY, 2022, 33 (10) : 1071 - 1082
  • [5] From Personalized to Precision Medicine in Oncology: A Model-Based Dosing Approach to Optimize Achievement of Imatinib Target Exposure
    Goutelle, Sylvain
    Guidi, Monia
    Gotta, Verena
    Csajka, Chantal
    Buclin, Thierry
    Widmer, Nicolas
    PHARMACEUTICS, 2023, 15 (04)
  • [6] A method for predicting target drug efficiency in cancer based on the analysis of signaling pathway activation
    Artemov, Artem
    Aliper, Alexander
    Korzinkin, Michael
    Lezhnina, Ksenia
    Jellen, Leslie
    Zhukov, Nikolay
    Roumiantsev, Sergey
    Gaifullin, Nurshat
    Zhavoronkov, Alex
    Borisov, Nicolas
    Buzdin, Anton
    ONCOTARGET, 2015, 6 (30) : 29347 - 29356
  • [7] Proteome based mapping and molecular docking revealed DnaA as a potential drug target against Shigella sonnei
    Shahid, Farah
    Alghamdi, Youssef Saeed
    Mashraqi, Mutaib
    Khurshid, Mohsin
    Ashfaq, Usman Ali
    SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2022, 29 (02) : 1147 - 1159
  • [8] Circulating Tumor DNA-Based Genomic Profiling Assays in Adult Solid Tumors for Precision Oncology: Recent Advancements and Future Challenges
    Chan, Hiu Ting
    Chin, Yoon Ming
    Low, Siew-Kee
    CANCERS, 2022, 14 (13)
1